Scientists at Queen’s University Belfast have discovered a new molecule which has the potential to prolong the life of individuals with cystic fibrosis (CF).
The molecule represents a possible future treatment and works by altering cellular ion channels resulting in improved airway hydration and significantly increased mucus clearance.
For individuals with CF, normal airway clearance mechanisms which keep the lungs free of infection are defective. As a result, a build-up of mucus occurs and predisposes the individual to chronic bacterial infection. The ensuing cycles of chronic infection and airway inflammation cause progressive destruction of the airways, which is ultimately fatal.
The innovative approach could reduce the frequency of these infections through a novel protease inhibitor which prevents activation of the epithelial sodium channel; ENaC.
The research involved a team of scientists from Queen’s University alongside colleagues at the Royal College of Surgeons in Ireland and the University of North Carolina, and was funded by The Cystic Fibrosis Trust.
Speaking about the breakthrough, Dr Lorraine Martin from the School of Pharmacy at Queen’s University Belfast, said: “This is an important finding which could provide a novel therapeutic opportunity relevant to all individuals with CF, as the targeting of ENaC is independent of their underlying CF mutation. This strategy could prevent the significant lung damage that results from chronic cycles of infection and inflammation, with potential impact on quality of life as well as life expectancy. This is a further example of Queen’s University’s research advancing knowledge and changing lives.”
Ed Owen, Chief Executive at the Cystic Fibrosis Trust, said: “We are thrilled with these initial findings and are excited to see how the next stage of preclinical testing progresses. We are pleased to have been able to fund this world class project at its early stage and welcome the drug development programme planned over the coming years. Research is the biggest single area of investment for the Cystic Fibrosis Trust and it’s wonderful to see projects like this making such positive progress in our fight for a life unlimited.”
Currently available pharmacological alternatives are only suitable for a small subset of patients depending on the disease-causing genetic mutation.
Learn more: QUEEN’S SCIENTISTS DEVELOP NEW TREATMENT TO PROLONG LIFE OF THOSE WITH CYSTIC FIBROSIS
The Latest on: Cystic Fibrosis
[google_news title=”” keyword=”Cystic Fibrosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cystic Fibrosis
- R400k boost for cystic fibrosis fighterson May 9, 2024 at 3:35 am
Breathtaking Fundraising, a non-profit that supports individuals with cystic fibrosis in South Africa, has received a R400,000 donation to address the significant challenge of medication ...
- Cystic Fibrosis Foundation board chair sheds light on rare diseaseon May 8, 2024 at 5:39 am
KC White from the Cystic Fibrosis Foundation joins Marc to share her personal experience with the disease and how CFF is helping raise awareness.
- 3 cousins traveling US Route 66 for Cystic Fibrosis awareness make stop in Amarilloon May 8, 2024 at 5:08 am
Three cousins traveling US Route 66 to raise awareness and funding for Cystic Fibrosis Awareness Month will drive through Amarillo in classic cars on Wednesday.
- Butte Calcutta raises more than $42,000 for Cystic Fibrosis supporton May 7, 2024 at 11:56 am
Organizers say the 10th annual Butte Cystic Fibrosis NCAA March Madness Calcutta was once again a success, raising $34,785 for the Cystic Fibrosis Foundation and another $8,500 for the Cody Dieruf ...
- Cystic Fibrosis Community Perspectives Influence Future of CF Care Modelon May 7, 2024 at 6:48 am
The Cystic Fibrosis Foundation conducted a national survey of people with cystic fibrosis, families, and clinicians to understand how CF care centers can adapt to meet the changing needs of people ...
- Vertex files FDA approval ask for next-gen cystic fibrosis candidate, resumes diabetes cell therapy trialon May 7, 2024 at 4:30 am
Vertex Pharmaceuticals is ahead of schedule, filing a new drug application for its next-gen cystic fibrosis (CF) treatment dubbed vanza triple. Vertex completed the regulatory submission a month ...
- Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drugon May 6, 2024 at 1:22 pm
By Paul Ziobro Vertex Pharmaceuticals posted double-digit sales growth in the first-quarter, topping Wall Street expectations, on continued growth of ...
- Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatmentson May 6, 2024 at 1:11 pm
Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday, driven by robust uptake for its cystic fibrosis treatments. Cystic fibrosis (CF) - an inherited disorder that ...
- Survey of US parents highlights need for more awareness about newborn screening, cystic fibrosison May 5, 2024 at 12:00 pm
A national survey led by Ann & Robert H. Lurie Children's Hospital of Chicago found that parents have insufficient knowledge of newborn screening in general and of cystic fibrosis (CF) in particular.
- A New Delivery System Offers Hope for Cystic Fibrosison May 1, 2024 at 7:52 am
CRISPR-carrying lipid nanoparticles enabled researchers to correct a rare nonsense mutation in the lungs of a cystic fibrosis mouse model.
via Bing News